Spotlight Interview: Susan Torroella, CEO & President, ArmadaHealth

About Susan Torroella Susan Torroella is CEO & President, ArmadaHealth. Most recently, she was Executive Vice President of Wellness Corporate Solutions where she contributed to its sale to LabCorp, shortly after her departure. Prior to WCS, Susan was President of FrontierMEDEX, acquired by United Healthcare International. During her tenure she oversaw

Industry News: Volume 2, Issue 24

SYNAPS Dx’s DISCERN™ Diagnostic Test Supports Payer Coverage and Prescribing Decisions for Lecanemab, Expected Breakthrough Treatment of Alzheimer’s Disease ROCKVILLE, Md.--(BUSINESS WIRE)--SYNAPS Dx (SDx), a privately held company focused on the research, development and commercialization of a diagnostic test for Alzheimer’s disease (AD), announces support for the nations’ payers in their coverage

Volume 2, Issue 23: Professor Yunkap Kwankam, Chairman, Board of Directors, and Dr. Thais Russomano, Member Telenethealth Advisory Board, Telenethealth, Discuss the Ability to Remotely Capture Data, Monitor Health and Capture Information from Any Medical Device

Dear Colleagues, I am thrilled to share that I had the opportunity to participate in a Congressional Briefing last week on behalf of the American Macular Degeneration Foundation. Sponsored by the Eye and Vision Research Institute and held at the Rayburn Congressional Office Building, this event brought together leading scientific researchers, the

Spotlight Interview: Professor Yunkap Kwankam, Chairman, Board of Directors, and Dr. Thais Russomano, Member Telenethealth Advisory Board

About Professor Yunkap Kwankam Prof. S. Yunkap Kwankam is a world-renowned expert on digital health. He holds a Ph.D. in electrical engineering and was elected to the following American honor associations: Eta Kappa Nu (Electrical Engineering), Tau Beta Pi (Engineering) and Sigma Xi (Research). He is currently CEO of Global eHealth

Industry News: Volume 2, Issue 23

AscellaHealth Named National Association of Specialty Pharmacy (NASP) Strategic Channel Partner of the Year BERWYN, Pa.--(BUSINESS WIRE)--AscellaHealth, a global healthcare and specialty pharmacy solutions company, is extremely honored to be named Strategic Channel Partner of the Year at the recent National Association of Specialty Pharmacy (NASP) Annual Meeting & Expo. This award is

Volume 2, Issue 22: Adam Brodsky, M.D., CardiacSense, Discusses Improving Outcomes Through Noninvasive, Long-Term Heart Monitoring Device

Dear Colleagues, According to a survey from the British Dental Association, an increasing number of dental patients in the UK are travelling to foreign countries to seek dental treatment. However, the association is urging dental care travelers to educate themselves on the risks and alternatives before deciding to receive treatment abroad. This

Spotlight Interview: Adam Brodsky, M.D., CardiacSense

About Adam M Brodsky, MD MM Adam M Brodsky, MD MM is an interventional cardiologist and medical advisor working with CardiacSense in Caesarea, Israel. He attended Medical School at Northwestern University Medical School in Chicago, IL, earning a combined MD MM degree at the medical school and the JL Kellogg Graduate

Industry News: Volume 2, Issue 22

Great Speech Develops Artificial Intelligence Platform to Refine Matching Process Between Patients and Most Qualified Speech Therapist HOLLYWOOD, Fla.--(BUSINESS WIRE)--Great Speech, a pioneer and leader in virtual speech therapy,today announces patient matching Artificial Intelligence (AI) technology to optimize pairing patients with the most qualified speech therapists in our network for

Volume 2, Issue 21: Michael Tu, Founder and CEO, Everyplace Labs Discusses Unique, Automated Self-Service Diagnostic Kiosk For Congregate Living Settings and Worksites

Dear Colleagues, The U.S. is a hot spot for medical tourists each year with patients often paying for expensive medical procedures out of their own pockets. However, the pandemic’s travel restrictions caused $1.9 billion of medical tourism revenue to be eliminated in 2020 and 2021, new research shows. This issue brings you